In this episode, Guillermo welcomes Phoebe Depree, Founder and CEO of Goddess Growers, who shares her journey into the cannabis industry and the creation of her brand. They discuss her business model, which involves licensing the brand to qualified manufacturers, and emphasizes the importance of retailer education. Phoebe highlights her unique product line of precisely dosed edibles designed for anxiety relief, incorporating THC, CBD, and a proprietary blend. The episode also covers market expansion, particularly in Ohio, and the potential impact of policy changes on the cannabis industry.
At the end of the day, cannabis is really a medicine, and it should be treated as such with caution, care, and education.” – Phoebe Depree
The finer details of this episode:
Episode resources:
Timestamps:
Introduction to Goddess Growers (00:00:27)
Phoebe Dupree, founder and CEO of Goddess Growers, introduces her company and its focus on cannabis edibles.
Entry into the Cannabis Industry (00:01:52)
Phoebe shares her personal journey of entering the cannabis industry, from being a consumer to founding Goddess Growers.
Licensing and Business Model (00:03:39)
Phoebe explains the brand licensing model, the role of manufacturers, and the focus on sales and relationships with retailers.
Educating Retailers and Consumers (00:05:28)
The discussion focuses on educating budtenders, obtaining state approvals, and establishing relationships with retailers to promote the brand.
Product Development and Market Expansion (00:07:00)
The conversation delves into the product's focus on specific remedies, the target consumer base, and the expansion into different markets.
Formulation and Targeted Effects (00:09:35)
Phoebe details the proprietary blend, cannabinoid profile, and the impact of terpenes and flavonoids on anxiety relief.
Market Entry and Consumer Education (00:10:38)
Phoebe discusses the current and future markets for Goddess Growers, emphasizing the importance of consumer education in the cannabis industry.
Policy Changes and Impact on Business (00:20:42)
The conversation shifts to the potential impact of policy changes, including the rescheduling of cannabis and its effects on taxation and access to capital.
Future of Cannabis Industry (00:21:51)
Phoebe shares her excitement about potential adjustments in banking, the impact on financial health, and the anticipation of a healthier industry.
Depository and Lending Challenges (00:25:09)
Discussion on the ease of obtaining checking accounts and the challenges of high-interest lending in the cannabis industry.
Transition to Cannabis Industry (00:27:49)
Phoebe Dupre's background in banking and transition to the cannabis industry, emphasizing the importance of financial decisions in a startup.
Understanding Time Value of Money (00:29:34)
Explanation of the time value of money in the antique furniture industry and its relevance to financial decision-making.
Sales Cycle and Branding (00:30:18)
Comparison of sales cycles in different verticals within the cannabis industry, focusing on the shorter sales cycle for cannabis brands.
Educational Initiatives (00:31:44)
Phoebe's involvement in educational initiatives, including speaking engagements, newsletters, and efforts to provide education to consumers.
Closing and Contact Information (00:33:14)
Final remarks, invitation for feedback, and sharing contact information for further engagement.
The timestamps have been extracted in chronological order and each topic has been given a title using Markdown.
Intro (00:00:02) - Welcome to the Cannabiz Success Show. If you're a cannabis company owner or operator who's ready to scale your business, grow your profits, and plant the seeds to take your business to new heights. This show is for you. We'll share expert insights, industry trends, and actionable strategies to help you blaze a trail of success in the cannabis industry.
Guillermo (00:00:27) - Welcome to the Cannabiz Success Show. Today we're going to be talking more about branding. I'm very excited because we haven't had a guest yet. That's more on the branding side of things. We've looked at different business models but Phoebe, we're excited to talk more about the branding side of things and just by way of introduction, our guest today is Phoebe DePree. She's the founder and CEO of Goddess Growers. It's a cannabis edibles company. She's leading a science and research-based team of visionaries. Phoebe has strategically positioned the lifestyle brand at the center of peace, calm and relaxation. I love those three words. We'll talk about the markets you're slated to launch, but Ohio and Illinois are too exciting.
Guillermo (00:01:19) - Just to give a little bit about, about goddess growers is, precisely dose product line that delivers a smooth and refined high end incorporating THC, CBD, THC, and Mother elixir. So, we'll get into cannabinoids very, very unique, product and really exciting to be talking about this. So, before we get into it, Phoebe, can you just give us your background and how you got into the cannabis space?
Phoebe (00:01:52) - Absolutely. Thank you so much for having me today. It's a real pleasure to be speaking with you. I, originally well, I'm a lifelong consumer and, supporter of cannabis and I started consuming, you know, as a teenager, for social reasons, around the campfire with friends in my 20s, I had a really, intense job in banking in New York and at the end of a long day, I would use it to kind of just lower my anxiety, and kind of come back to that center and in my 30s, I had three babies in a row, and they started sleeping through the night.
Phoebe (00:02:31) - And I always say I stopped sleeping for the night, and cannabis is really. It helped me to sleep and then my 40s, I entered the cannabis industry, and founded Goddess Growers in January 2020. Initially, you know, I looked at getting a cultivation license in Illinois, but quickly realized that there was a huge opportunity for a brand and so, I pursued creating the Goddess Growers brand, specifically edibles. I'm a 45-year-old mom with three little kids. I wanted something discreet that could really help me take the edge off. Sort of in place of that glass of wine at the end of the day.
Guillermo (00:03:18) - And in the listeners when you when you say you, you applied for. So, when you're a brand. Right. Because we've talked to those who have cultivation and retail licensing in the markets that you're in, is there a separate brand for is there a separate licensing process for a brand versus a retailer? Can you talk a little bit about that?
Phoebe (00:03:39) - Yeah.
Phoebe (00:03:39) - So, there's no licensing process per se as a brand. The way I describe myself is, think of Coca-Cola has their secret syrup and their beautiful brand, and they license it to franchisees now, Coca-Cola does own some franchisees, but then oftentimes they'll just license the brand and so, I, I've pursued a similar model where I, I look for manufacturers that represent the values. They have the right amount of industry Intel, capitalization and a CGMP certified good manufacturing facility and we will license our brand to them and then my food scientist comes in and trains their kitchen how to make our products. They distribute them and I generate the sales.
Guillermo (00:04:27) - Okay. So, when you have this type of business model it is so like you said your focus is on sales and are you connecting because I always try to bring it back to your relationships. Are you from the sell side? Are you going out and connecting with retailers or is the manufacturer part? So, is the retailer your primary customer that you're out and connecting with?
Phoebe (00:04:50) - That's right.
Phoebe (00:04:51) - That's exactly right. We're really establishing relationships with retailers, educating them on our products and the value proposition for the end consumer and then we have to go through every state, as I say, like its own country. So, in Ohio, for example, there are, a lot of approvals for your packaging, for example, and your formulations, you need to get state approvals, but that would all go through your partner manufacturer who does have that cannabis license. We don't we don't have a license. We're not interested in pursuing one at this time.
Guillermo (00:05:27) - Yeah.
Guillermo (00:05:28) - And how do you when you're dealing at the retail level, there's, there's two layers, right because you're trying to educate the retailer. The retailer has to educate the consumer and so, how have you been able to, to work that piece of educating folks about, I assume, how your product works, the minor cannabinoids, and different things.
Phoebe (00:05:54) - You know I find that the population of bud tenders, the folks that are selling in these retail dispensary locations are incredibly educated and interested in learning about brands.
Phoebe (00:06:06) - And so, you do you do have their ear to, to train them on, you know, why you made certain decisions. You know why you have the cannabinoid profile. You do who you, your target customer is we are focused on anxiety and, taking the edge off, really the journey to calm and so all the decisions and selling points that we make are really about that and then we also, are starting a newsletter to provide educational material to the end consumer, in addition to the bud tender, to try and then drive traffic into the dispensary and you know, teach them not only about our brand, but about the cannabis industry in general in ways that you can, safely incorporate, cannabis that's produced in a licensed facility, sold in a licensed dispensary.
Guillermo (00:07:00) - Yeah. And so, your product is focused on the consumer looking for specific remedies. Right? Whether it's sleep calm and really, consistent and that requires, right. Like you said, a lot of education consistency around the product.
Guillermo (00:07:21) - Are you finding that is it in certain markets where this consumer base is continuing to grow? versus the, you know, the high THC type of consumer where folks are really looking for that specific effect and they're looking for a form factor that is, like yourself that's more, discreet or, such as the edible category.
Phoebe (00:07:49) - Yeah. I'm finding that, instead of looking at THC level, thinking about, the end state that a consumer is looking for, and, you know, if they are feeling anxious at times and looking for a way to take the edge off, then we would be the product for you and we've we are in market with varied levels of THC. So, the more seasoned cannabis consumer will find something for themselves in addition to a newer cannabis consumer or a more seasoned one that has a very low tolerance. I put myself in that category. I consume cannabis almost daily but in very low doses, you know, 1 to 3mg five. If you know it's the weekend, I'm going to a concert.
Guillermo (00:08:36) - I, I'm, I'm the same way when I go to, to conferences and I'm socializing, having to having to socialize with, with everybody and consuming cannabis is just like, I can't, I can't stay awake. So, it's just like, I'm that same type of consumer that, I'm looking for something very low dose and for very, specific, effects on my body that I can predict and what is what is going to happen there with, with the dosage. so can you when you're talking about your product, is there, anything in terms of, you know, the manufacturing process that consumers are, are looking for, with the value of the, of the product or anything that you share when you're, working with, different retailers, to, to talk about your product, essentially sell your product and promote it out in the marketplace.
Phoebe (00:09:35) - You know, I guess the messaging is where the sum of all parts this a brand is, we worked over multiple years with. Plant biologists, neuroscientists, food scientists to develop a product that has a targeted effect on anxiety for most people.
Phoebe (00:09:54) - And we even developed a proprietary blend of terpenes and flavonoids that augments that feeling of calm. In addition to the cannabinoids we're providing, the arrangement cannabinoids that we feel is a hybrid that provides that feeling of calm and that's the mother elixir is the, the proprietary blend.
Guillermo (00:10:18) - I see. And in terms of markets, can you go back and kind of talk about that, the markets and that you're in because I'd like to eventually get into, how those markets are, are developing. Can you start with what market you're currently in and where you're looking to go?
Phoebe (00:10:38) - Yes. We're currently selling into Ohio, which is a medical market that is about to flip into adult use and you know, at the end of the day, Canis is really a medicine and it should be treated as such with caution and care and education and you see that a lot in medical markets and then ushering in adult use and just really making sure that, the adult use consumers are educated.
Phoebe (00:11:10) - Everybody is the endocannabinoid system is unique and everyone has receptors in different places. for those of you who haven't heard of the endocannabinoid system, it's also referred to as the ECS. It's your body's own weed system essentially, and it's a neurological relationship. It's not a physical one, like alcohol which can affect your brain stem. If you have too much, it can make you stop breathing. Cannabis will never do that t's a neurological relationship, and I always like to talk about it. Like the volume on your car radio, it can turn the volume way up or way down, but really understanding what your unique system requires in terms of dosing and it's not just THC, it's the, the other minor cannabinoids as well. I consider it a little bit of a barrier to entry for somebody that's never consumed, because it takes a minute. You know, if you think about alcohol, everybody knows whose consuming alcohol, how one glass of wine or one cocktail or one beer makes you feel.
Phoebe (00:12:10) - So, if you're new to cannabis taking that time, I always suggest at the end of the day when you don't need to go anywhere or do anything you know, and maybe you're seeing your bed reading and you can try a very low dose of a new product. See how it makes you feel.
Guillermo (00:12:24) - Yeah, I'm glad you brought that up. And the comparison to alcohol. We had a guest a couple of weeks ago and he brought up some of the language that we use in terms of how we like I brought up the hemp market and how some states are banning what they deem intoxicating hemp products, and he pointed out that it's, the language is actually incorrect because it's not intoxicating it's euphoric, but it's really not a toxic substance to the body. Right? And what you describe there is how it works with your body. It's very different from alcohol, in the sense that many of us have consumed alcohol for many years and so, you know, exactly hopefully what you can and can't consume.
Guillermo (00:13:12) - Right. And the effect that it's going to have on you but with cannabis, especially in a, in a market where, with the consumer base, that's, that's the curious or that's trying for the first time, it's really important to even though it's not technically toxic to the body, it can have a, an effect that you may not want. Right. So, that education pieces are really important. The other piece I wanted to get to be, the, the terpenes and you mentioned education, and that's a big part of it because that is really missing, is education around the turbines. You know, I, I know I have my way of understanding what they are, but it'd be great if you could share about that.
Phoebe (00:13:56) - Absolutely. So, I interviewed the end consumer and ultimately decided we wanted to target anxiety and then I started to think about arrangements of cannabinoids, but not just cannabinoids. We hear about THC and CBD a lot and as you astutely mentioned there's, you know, over 120 cannabinoids, but then there's also terpenes and flavonoids.
Phoebe (00:14:20) - And those can sway the effect that a consumer has as well. So, we, I'm of the belief that the plant and its whole form is the best. and then, of course, there's different strains. So, what we determined is having using, full spectrum CBD to offer that alphabet soup of minor cannabinoids in addition to THC, distill it and then I, I got a lot of feedback, especially from women and I feel this way as well. I love to consume cannabis. I don't want to get the munchies and so, we found that adding in a little bit of TCV, I also don't want to feel drowsy necessarily. I wanted to create a daytime high, or, as you say, if you're going out in the evening but don't want to be falling asleep, that was the effect I was looking for. Relaxed but alert. So, we found by elevating, TCV, and many people, it won't give you the munchies and it will provide a degree of focus in addition to that feeling of calm.
Phoebe (00:15:28) - And then we took it a step farther and looked at terpenes and flavonoids, and I developed this proprietary blend people often say, well, what's in the blend? You know, I say it's a lot of, mostly, on the terpene side, limonene and little, limonene you can think of like citrus fruit would have some limiting in it like a lemon peel. and then the flavonoids are the flavoring. We also have, you know, that that's proprietary as well and all that goes on that path of relieving anxiety, providing a degree of calm. So, it was really thinking about the end state, the desired end state, and then backing into it with our formulation. We do have a higher dose of gummy available in Ohio. It's 40mg of full spectrum CBD and 40mg of THC at that higher dose, I did not, the TCV because, as you alluded to earlier, if you have certain cannabinoids in higher doses can have the opposite effect.
Phoebe (00:16:31) - THC is one of them and we didn't want to create anxiety. So, we've just got this 1 to 1 at a higher dose because it is that medical market and we do see patients that that want and more seasoned consumers that they're looking for that higher dose to attain that desired effect of calm.
Guillermo (00:16:49) - Yeah. And as you mentioned this you know, the combination of this can it does provide a more consistent effect, right? because I have purchased THC extract, like, alone as a tincture and it's just like you said, it's different for everybody and I know that sometimes it has helped me focus, but I've done it. I've taken it other times where it makes me drowsy. Right? And so, the, the terpenes, when you're consuming in a, not the, the full flower, but, in a, in an edible, form factor, the terpenes have any effect on, flavor or any experience for the consumer or is that more just when you're consuming? in the flower category? I know you mentioned that it has like, the effect it it's it has an effect, but it, does it have any anything to do with the experience that the consumer experiences when they're consuming?
Phoebe (00:17:59) - Yeah, absolutely.
Phoebe (00:18:00) - Flavor does play a role in how you feel. You know, if you ever crave a food and it tastes so good, it's kind of what your body needs in that moment. and then with the turbines, turbines can be very smelly and stinky, and you want to really use them in tiny amounts, I've found and then we I didn't talk about this yet, but we've partnered with Azuka, which is a fast-acting ingredient, and it encapsulates all of the molecules in our edible, and it in addition to, making it hit your system in 5 to 15 minutes, it can mass that the taste. Now, some people love the cannabis taste, others don't. You know, ultimately, ours does not really taste like cannabis at all. You can barely taste any cannabis, or terpenes. I really like Azuka. All their ingredients are approved by the FDA you know, we really, went to great lengths to make sure every input into our, our gummies are, is really, carefully chosen and safe for consumption because it's food and you're putting in your body at the end of the day.
Guillermo (00:19:08) - Yeah.
Guillermo (00:19:09) - So, let's take.
Guillermo (00:19:10) - Take it back more to the to the business side. Thanks for sharing all that. I think our listeners will find that educational and I mean, this seems like basic, basic things to those who've been in the industry at least some time or long time, such as yourself but I think some of these basics are, are the things that that folks need to hear, because there's still such a large segment of the market that is, that is not aware of the minor cannabinoids of how terpenes and flavonoids work. So, so, thank you for that. but going back to there's a lot going on right now. Right, with the, with the potential reschedule but you mentioned being an asset light business model. You're able to operate in different markets, right? Yeah. It is a rec-market, but so when you think about it, you're essentially able to expand into any particular market that you find a partner in was that a big part of choosing this business model? Is that, like, you don't have to apply for a different license in each state? And do you see that in your future? Is that, you know, we talk a lot about, or we've brought it up if we see a potential, interstate commerce down the road.
Guillermo (00:20:32) - But that is just not something that really affects you under your current business model, right? Any in terms of interstate commerce or how the rescheduling could impact you?
Phoebe (00:20:42) - That's correct. interstate commerce wouldn't so much affect us. I mean, there would certainly be some effect, but I like the ability to be everywhere and nowhere. It gives us flexibility to carefully choose our partners, and then this is still a bit of the Wild West. The market has come so far, but there's still a lot of work to be done and being able to grow, you know, as we see fiit I really enjoy that degree of freedom and flexibility as a brand.
Guillermo (00:21:20) - Yeah.
Guillermo (00:21:20) - What are you, what are you most excited about right now? Like. obviously, the potential of two and going away, but what are you most excited about in the industry right now? Because, I mean, this is just really a, a big year, a lot going on, policy, changes that are really pushing things forward, perhaps, might start to see institutional capital in the future.
Guillermo (00:21:46) - But can you share what you're most excited about?
Phoebe (00:21:51) - You know, as far as the policy, the rescheduling was a big deal it's I tell people that we're riding a snail, and that these things take time. but rescheduling, it won't be immediate, right? There's a comment period. It'll take a little while. It may have been a couple of tax cycles before; companies see that relief at the federal level but not being subject to aid is a huge deal. If you're considered plant touching by the IRS 280, for those of you that are not familiar, it's a tax code. and as a schedule and substance, cannabis was a schedule and substance, is something that has no medicinal value, which we know Cannabis. That's not true. They've rescheduled it to schedule three and it's great because now schedule three drugs does have some additional value, and it's not subject to 200, which is significant because, it used to be you couldn't write off things like your employees' wages or your rent, which is a business owner.
Phoebe (00:22:52) - If you think about that. That's pretty egregious and it's really hard on a business. I'm most excited, I think the next step will be some sort of adjustment in banking to create a little bit of a healthier environment financially for companies. You know, as a startup, I couldn't apply for an SBA loan, for example, because it's technically federally illegal. I don't know what way it will go. It just does seem like, the motion and the motion is going in the right direction and whether it's a safe Banking Act passing in Congress or whether the government legalizes at the federal level and then kicks it to the states to decide, and that opens up the, some room for traditional banks to, start providing lending. It'll just create a much healthier industry and because you are seeing so much capital poured into the cannabis industry, I think will be an excellent next step. It's just anybody's best guess when that will happen.
Guillermo (00:23:53) - Yeah, I've just looked at it like, okay, the reschedule is not a safe.
Guillermo (00:23:59) - It's not a path to safer banking for say exactly like that it doesn't mean that safer banking will pass now, but I always say like there are still plenty of banks that are banking cannabis. I forget the number, but there's a number out there and it's pretty high of how many banks are banking cannabis, the kind of side effect that it will have is that to your point, on 280 going away is that companies will just will be more profitable overnight, just by a lower rate of taxation or not the rate, but just the effective tax rate at the end of the day and so just companies have better credit and are more, banks are more likely to loan to a bank, company that has better credit, that is more, that is more profitable. So, I see that as a, as a, not exactly the direct path, but an effect that it's going to have on cannabis is that it is going to improve, access to capital because just companies will be more can be more profitable with not being subject to 280.
Guillermo (00:25:09) - And then over time, just by the by way of the industry, just, just learning, you should have some relief of the price compression that you have in, in almost all the markets as, as companies just get larger and perhaps more consolidation but since I always make the point that there is enough banking to go around for current, cannabis companies, I say this kind of just anecdotally when I talk to, you know, folks out there from your standpoint, did you have any issues, just from a depository standpoint, getting, a relationship with a bank just for regular checking and savings and treasury management service for your day to day operations or was that a struggle as well?
Phoebe (00:25:54) - No, that was not a struggle. Getting a checking account is fairly easy as you say there's plenty of credit unions and I've found, you know, that to be easy. It's the lending that's the hard part, you know, and that's what the Stafford Banking Act or, you know, legalizing cannabis at the federal level and having the larger, you know, FDIC insured banks come in, it'll just you'll see compression in the interest rates that that are being solicited for loans in the cannabis industry right now are, you know, sometimes up to 20%, which is just ridiculous.
Phoebe (00:26:27) - And it's really hard to, it's just not a healthy, financial model to have such high rates. So, I would say it's more like on the lending side, and, you know, providing that capital for companies once they have that proof of concept to really grow.
Guillermo (00:26:44) - Sometimes it makes sense to borrow. Right. If your cost of borrowing is less than the profit you're generating in terms of percentages, how I think about it, but when you're borrowing at a credit card rate, it's hard to justify. Like you said, even if the lending is there, it's at such a high rate that it doesn't make sense. You'd have to make a high margin to cover that cost of borrowing, that cost of capital. So, yeah, one more example that I can add to my research study there that I have not come across a, a cannabis company that has had issues obtaining a, a checking and a savings account.
Guillermo (00:27:28) - It's more, on the lending side, as you say. Phoebe let's go back to your story. So, you have a background in banking was there a moment when, when you got out of banking and decided to get into cannabis, and how does that banking background play into what you're doing today?
Phoebe (00:27:49) - Sure. So, I worked in banking at college for some years, and then, I think I'm technically called a serial entrepreneur, maybe something in that category because I went and started a business. I've always loved antique furniture, and I noticed that antique furniture dealers didn't take into account the time value of money and so I started a business selling antique furniture for some years and then I took a pause when I had my babies and around that time during the pause, Illinois was going adult legal adult use was starting in my home state, Illinois and I have a cousin that has a vertically integrated operation in Colorado, and I initially went to him and said he should apply for a license in Illinois.
Phoebe (00:28:37) - And ultimately I ended up applying and not getting license and pivoting into this brand and so that's sort of how I found my way but having a, that, that finance background has been helpful just in terms of the decisions that we make as a startup, you know, it's so perilous and I feel like, you know, oftentimes there's just a lot of shiny objects and maintaining the focus, and making sure every dollar we spend is going towards helping me to get off of a shelf and, you know, illustrate the value, that our product is, is going to provide and really, you know, providing the education that we're endeavoring to provide. So, I think definitely it has been helpful along the way.
Guillermo (00:29:25) - And when you say, in that in the antique furniture industry didn't understand the time value of money. Can you explain that?
Phoebe (00:29:34) - Oh, sure. Not that they didn't understand it. I don't think that there was an appreciation for it. So, what I mean is, if an antique furniture dealer bought a chair, a really beautiful chair on day one, and let's say Andy 20.
Phoebe (00:29:49) - Somebody offered them their money two times. They might say no because they think they can make five times, and they may, but it may take them five years and when you model that out, it would be so much more profitable. I mean, imagine somebody came to you in the stock market and said, hey, in 20 days I'm going to double your money. You would be all over that. and so, you know, doubling your money and then redeploying that capital and buying more inventory and then selling that over a faster period of time. That's what I mean by the time value of money.
Guillermo (00:30:18) - Right?
Guillermo (00:30:18) - Yeah. The sales cycle. Right. Because that comes into play in the different verticals within cannabis. Like you mentioned, your brother is fully vertical, I think you said and so the.
Phoebe (00:30:31) - Oh, cousin, my cousin.
Guillermo (00:30:32) - Cousin.
Guillermo (00:30:33) - I'm sorry.
Guillermo (00:30:34) - Has a there's a different sales cycle from the time it takes to plant a seed to sell it to, a manufacturer versus a brand such as yourself.
Guillermo (00:30:44) - Right. And so, would you say, like, a brand has a much shorter sales cycle, than other pieces of the vertical?
Phoebe (00:30:54) - You could say that. Yes. because we are taking that end product distillate and put it, you know, producing it into edibles and then, distributing it and selling it. You're sort of starting; you know, you're not starting from the seed going into the ground. but, you know, you're, you're paying that cost like there's an associated cost of goods that comes with that as well. So, it's not a total sweep.
Guillermo (00:31:21) - And, and education, going back to the educational piece, you've been involved with, policy a normal, where are you involved in, in anything that's, educational, agencies or anything like that where you provide education to consumers.
Phoebe (00:31:44) - You know, I, I'm a member of the Illinois Women in Cannabis, and I've been in a couple of their panels. and then we're starting a newsletter. Got us growers to provide a monthly sound bite article on a topic we think is important to send into the market.
Phoebe (00:32:05) - And you can sign up on our website, Goddessgrowers.com. So, those are ways I'm starting. And then I've also been speaking to, groups of women. Any, you know why? Or, a garden club, has been helpful. I'm very interested in talking to the elderly as well. It's been a little bit more challenging, finding a speaker spot at a nursing home, but that's on the horizon, I hope, as well.
Guillermo (00:32:35) - Yeah. So, I mean, I consider our podcast is the, the education and d stigmatization a big part of what we hope to accomplish in, in each of our episodes and I think we did a lot of that with, with what you've shared about minor cannabinoids and terpenes and just your journey. So, we appreciate you being on the show and, and sharing your story. I think you shared a lot that our listeners will benefit from before we start to wrap up, was there anything else that we didn't cover that you'd like to cover before we wrap up?
Phoebe (00:33:14) - No. If there are any questions that we didn't cover, you can also go to our website, Goddessgrowers.com, and there's some contact info on there I'd be happy too. You know, I love to hear feedback and questions that folks have. We're constantly collecting those but thank you for having me on today. It was a real pleasure chatting with you.
Guillermo (00:33:32) - Yep. Thank you. And, Yeah, definitely. Check out the newsletter and is, are you active on LinkedIn or what's where's the best place for people to find you personally?
Phoebe (00:33:43) - I'm on LinkedIn, Phoebe DePree.
Guillermo (00:33:47) - All right. It'll be in the in the show notes. That's all we have for today. Thanks, everyone, for joining us today and we'll see you next time on the Cannabiz Success Show.
Intro (00:33:58) - Enjoy this podcast. Visit our website Anders cpa.com/virtual-CFO- cannabis to get more tips and strategy for achieving business success in the cannabis industry.